y In an article in Monday's BioWorld Today, it was stated that MatthewMurray, an associate analyst in the New York branch of Alex BrownInc., "raised concerns about the ability of genome companies to acquirepatents." In fact, Mr. Murray is a firm believer in the potential ofgenome companies. Mr. Murray said that he is confident that genes canbe patented. His comments on the possibility of an interference beingcalled by the U.S. Patent and Trademark Office were related to aparticular case of a colon cancer gene discovered by Human GenomeSciences, Inc.y Two recent articles about Neurex Corp. misspelled the name of theMenlo Park, Calif., company's chief executive officer, Paul Goddard.

(c) 1997 American Health Consultants. All rights reserved.